Pradžia › Amiloidozė › Oregon
Amiloidozė klinikiniai tyrimai Oregon
6 tyrimai dėl Amiloidozė ieško dalyvių vietose Oregon.
Miestai Oregon
Oficialus tyrimo tekstas (anglų kalba)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Portland
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-23 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Portland
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Oregon Health & Science University, Portland
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-04 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Oregon Medical Research Center /ID# 255119, Portland
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-13 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
- Oregon Health & Science University, Portland
Renkami dalyviai2 fazė
Amžius nuo 40 iki 90 · Visoms lytims · Atnaujinta 2026-04-13 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Oregon Health and Science University (OHSU), Portland
Renkami dalyviai3 fazė
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-03-27 · NCT06128629Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.